COMMITTEES TO HEAR TESTIMONY ON MEDICAL USE OF CANNABIS AND HEMP-DERIVED CANNABIDIOL

WHO:             Representative John Mizuno, Chair, House Committee on Health

Senator Rosalyn Baker, Chair, Senate Committee on Commerce, Consumer Protection and Health

WHAT:          Informational Briefing on cannabis and hemp-derived cannabidiol

WHEN:          Thursday, September 12

                        9:30 a.m.

                       

WHERE:       Hawaii State Capitol

                        Room 329

Honolulu, Hawaiʻi –The House Committee on Health and the Senate Commerce, Consumer Protection, and Health Committee will hold an informational briefing to review Hawaii's policy on Medical Cannabis and improve the safety of integrative healthcare options for Hawaiʻi's people based upon recent scientific research and best practices in other jurisdictions.

Hawaiʻi is faced with potential public health risks arising from consumption of unregulated sales of products reportedly containing CBD on the internet and through so-called CBD dispensaries, spas, gyms, health food stores, convenience stores, and even gas stations.

This briefing will seek to accomplish these four goals:

• Examine the benefits of Medical Cannabis therapy including as a safe alternative to prescription opioids for pain relief
• Understand the risks associated with human consumption of unregulated hemp-derived CBD; review state hemp cultivation and manufacturing policies and CBD regulations in other jurisdictions
• Review other jurisdictions who provide for rational protections for employees registered in the state’s Medical Cannabis Registry program.
• Begin a discussion about Hawaiʻi’s need for a well-considered, thoughful transition to a “dual use” program that allows both medical and adult social use of cannabis.

To see the hearing notice, go to: https://www.capitol.hawaii.gov/session2019/hearingnotices/HEARING_CPH-HLT_09-12-19_INFO_.HTM

No public testimony will be accepted.